Well done to Simmunome Inc., Neuro Solutions Group and IVANO Bioscience for delivering stellar pitches to our panel of investors! These companies, from our Quebec Hypergrowth cohort, are tackling major challenges in biotech, digital therapeutics and AI-driven drug development - each with the potential to reshape their industry.
🚀 We just wrapped up an incredible pitch session featuring three cutting-edge, female-led Quebec startups from our Startup Genome Hypergrowth program: IVANO Bioscience, Neuro Solutions Group, and Simmunome Inc. These innovators are tackling major challenges in #biotech, #digital #therapeutics, and #AI-driven #drugdevelopment — each with the potential to reshape the industry. 🔹 Here are the Key Highlights: ✅ 15+ investors, representing #angels, #VCs, and #family offices focused on #lifesciences and #digitalhealth. ✅ Startups are raising between $1.5M-$8M for expansion and product development. ✅ Lively investor engagement with deep dives into clinical validation, business models, and go-to-market strategies. 💡 What’s Next? ➡️ Investors are providing additional feedback to help founders refine their pitch and positioning. ➡️ Founders are being introduced to new connections. ➡️ The momentum continues as these companies push toward global impact. Missed the session but curious about the companies? Comment below and I'd be happy to make an introduction! A huge thank you to the investors and founders who made this such a high-value session! #Startup #Pitches #LifeSciences #HealthTech #QuebecTech #StartupGenome Thank you Anastasia Vintras and Québec Tech for your partnership.
